10.1007/s10620-017-4470-9 17 CaiW.SakaguchiM.KleinriddersA.Gonzalez-Del PinoG.DreyfussJ
The NIH reports that only about 10 micrograms of a 500-microgram oral supplement is actually absorbed in healthy people due to limitations of stomach acid and intrinsic factor
Reported effects in animal models include improved wound closure, modulation of inflammation, and support for cardiac and corneal tissue repair
BPC-157 is not approved by the FDA for human or veterinary use, and in the United States it is handled as a research compound
Rare risks associated with GLP-1 medications include: Pancreatitis , or inflammation of the pancreas Gallstones and inflammation of the gallbladder leading to biliary colic, sometimes related to rapid weight loss Kidney issues , often linked to dehydration Thyroid tumor warnings , based on animal studies rather than confirmed human cases These risks underscore the importance of medical supervision throughout your treatment
The drops can be effective, but absorption is lower than injectable forms